| 引用本文: | 庞美蓉,蔡丽红,龚一川,吴彬斌,田青竹.浙江省医药行业海外知识产权保护现状与建议[J].中国现代应用药学,2022,39(7):971-975. |
| PANG Meirong,CAI Lihong,GONG Yichuan,WU Binbin,TIAN Qingzhu.Current Status and Suggestions on Overseas Intellectual Property Protection of Zhejiang Pharmaceutical Industry[J].Chin J Mod Appl Pharm(中国现代应用药学),2022,39(7):971-975. |
|
| 摘要: |
| 目的 深入贯彻落实国家知识产权保护战略，调研、分析浙江省医药企业的知识产权保护现状，为政府、社会和相关企业提供建议与参考。方法 实地调研了解企业知识产权保护意识，统计企业专利信息与海外诉讼信息，明晰行业专利运营现状，结合国内外已有风险防控模式提出建议。结果 明晰了浙江省医药行业知识产权海外维权面临的主要问题与挑战，提出了国家、地方与企业3个层面的对策。结论 面对新形势下浙江省医药行业海外知识产权保护的现状、问题与挑战，政府与社会各界要相互联动，推进海外知识产权保护体系建设。 |
| 关键词: 知识产权 医药行业 海外风险 |
| DOI：10.13748/j.cnki.issn1007-7693.2022.07.019 |
| 分类号:R95 |
| 基金项目:国家知识产权局软科学研究项目（SS21-B-20） |
|
| Current Status and Suggestions on Overseas Intellectual Property Protection of Zhejiang Pharmaceutical Industry |
|
PANG Meirong, CAI Lihong, GONG Yichuan, WU Binbin, TIAN Qingzhu
|
|
Zhejiang Intellectual Property Protection Center, Hangzhou 310012, China
|
| Abstract: |
| OBJECTIVE To the thorough implementation of the national intellectual property protection strategy, investigate and analyze the intellectual property protection status of pharmaceutical enterprises in Zhejiang province, in order to provide references and suggestions for the government, communities and relative enterprises. METHODS Fathomed intellectual property protection awareness of enterprises through on-site investigations, examined corporate patent's operation status through analyzing corporate patent statistics and overseas litigation information, and devised suggestions referring to existing risk prevention and control patterns at home and abroad. RESULTS The major concerns perturbing the overseas intellectual property protection of Zhejiang pharmaceutical industry were clarified, and countermeasures were devised, addressing three levels of government level, local level and enterprise level. CONCLUSION Confronting the situation, concerns and challenges of overseas intellectual property protection of Zhejiang pharmaceutical industry, all sectors of society shall dynamically foster synergy to bolster the construction of the overseas intellectual property protection system. |
| Key words: intellectual property pharmaceutical industry overseas risks |
